Xiangning Qiu

943 total citations
24 papers, 700 citations indexed

About

Xiangning Qiu is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Xiangning Qiu has authored 24 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 7 papers in Molecular Biology and 7 papers in Rheumatology. Recurrent topics in Xiangning Qiu's work include Systemic Sclerosis and Related Diseases (8 papers), Dermatologic Treatments and Research (4 papers) and RNA modifications and cancer (4 papers). Xiangning Qiu is often cited by papers focused on Systemic Sclerosis and Related Diseases (8 papers), Dermatologic Treatments and Research (4 papers) and RNA modifications and cancer (4 papers). Xiangning Qiu collaborates with scholars based in China, United States and Denmark. Xiangning Qiu's co-authors include Yaping Li, Peter A. Jones, Nan Hu, Yongqi Luo, Jun Yuan, Guiying Zhang, Qianjin Lu, Qianjin Lu, Ying Zhou and Yu‐Wen Su and has published in prestigious journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiangning Qiu

23 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangning Qiu China 9 415 227 155 138 82 24 700
Lorenzo de la Rica Spain 10 449 1.1× 198 0.9× 103 0.7× 74 0.5× 53 0.6× 12 644
Simon Bornschein Belgium 12 316 0.8× 295 1.3× 161 1.0× 55 0.4× 128 1.6× 15 665
Xingwen Dong United States 9 266 0.6× 224 1.0× 76 0.5× 72 0.5× 33 0.4× 15 528
Chiara Angiolilli Netherlands 11 252 0.6× 172 0.8× 72 0.5× 108 0.8× 53 0.6× 16 512
Annie Yarwood United Kingdom 13 237 0.6× 290 1.3× 40 0.3× 201 1.5× 68 0.8× 20 682
Anke K. Bergmann Germany 12 244 0.6× 94 0.4× 61 0.4× 79 0.6× 113 1.4× 34 524
Ari Itoh‐Nakadai Japan 16 340 0.8× 530 2.3× 56 0.4× 28 0.2× 80 1.0× 22 861
Soumen Chakraborty India 13 434 1.0× 88 0.4× 50 0.3× 38 0.3× 197 2.4× 27 635
Yingzhe Yu China 9 195 0.5× 215 0.9× 84 0.5× 61 0.4× 195 2.4× 23 626
Laura Bergamaschi United Kingdom 10 193 0.5× 223 1.0× 60 0.4× 45 0.3× 24 0.3× 15 444

Countries citing papers authored by Xiangning Qiu

Since Specialization
Citations

This map shows the geographic impact of Xiangning Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangning Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangning Qiu more than expected).

Fields of papers citing papers by Xiangning Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangning Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangning Qiu. The network helps show where Xiangning Qiu may publish in the future.

Co-authorship network of co-authors of Xiangning Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangning Qiu. A scholar is included among the top collaborators of Xiangning Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangning Qiu. Xiangning Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Yixin, Xueqin Zhang, Lu Li, et al.. (2025). Influential Factors in the Efficacy and Safety of Hemoporfin‐Mediated Photodynamic Therapy for Facial Port‐Wine Stains. Journal of Cosmetic Dermatology. 24(4). e70153–e70153.
2.
Shi, Yaqian, Zhuotong Zeng, Xinglan He, et al.. (2024). Silica's silent threat: Contributing to skin fibrosis in systemic sclerosis by targeting the HDAC4/Smad2/3 pathway. Environmental Pollution. 355. 124194–124194. 2 indexed citations
3.
Xiao, Yangfan, Yaqian Shi, Zhuotong Zeng, et al.. (2024). The Price of Beauty: A Literature Review on Non-Tuberculous Mycobacteria Infection After Cosmetic Procedures. Aesthetic Surgery Journal. 44(8). NP574–NP584. 2 indexed citations
4.
Tang, Rui, Xinglan He, Yaqian Shi, et al.. (2024). MiR-4769-3p suppresses adipogenesis in systemic sclerosis by negatively regulating the USP18/VDAC2 pathway. iScience. 27(8). 110483–110483. 1 indexed citations
5.
Xiao, Yangfan, Xinglan He, Rui Tang, et al.. (2023). ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis. International Immunopharmacology. 121. 110420–110420. 1 indexed citations
6.
7.
Shi, Yaqian, Yangfan Xiao, Yan Ding, et al.. (2023). UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in scleroderma. International Immunopharmacology. 116. 109764–109764. 6 indexed citations
8.
Qiu, Xiangning, et al.. (2023). Activating Protein-1 (AP-1): A Promising Target for the Treatment ofFibrotic Diseases. Current Medicinal Chemistry. 31(7). 904–918. 4 indexed citations
9.
Deng, Qiancheng, Pei Du, Yaqian Shi, et al.. (2022). Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo. International Immunopharmacology. 114. 109574–109574. 5 indexed citations
10.
Zeng, Zhuotong, Yaoyao Wang, Yangfan Xiao, et al.. (2022). Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4+ T cells in systemic sclerosis via IRF1 signaling. Arthritis Research & Therapy. 24(1). 50–50. 7 indexed citations
11.
Xiao, Yangfan, Zhuotong Zeng, Xiangning Qiu, et al.. (2022). Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling. Pharmacological Research. 176. 106057–106057. 12 indexed citations
12.
Shi, Yaqian, Zhuotong Zeng, Xiangning Qiu, et al.. (2022). Bullous lichen sclerosus–generalized morphea overlap syndrome improved by tofacitinib. Dermatologic Therapy. 35(12). e15942–e15942. 4 indexed citations
13.
Gujar, Hemant, Hongtao Li, Yvonne Tsai, et al.. (2021). Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma. Genome Medicine. 13(1). 130–130. 12 indexed citations
14.
Chen, Pan, et al.. (2019). Hyper IgE Syndrome with Large Recurrent Head Abscesses Misdiagnosed as Folliculitis. Acta Dermato Venereologica. 99(7). 697–698. 1 indexed citations
15.
Luo, Shuang, Yu Liu, Gongping Liang, et al.. (2015). The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clinical Epigenetics. 7(1). 24–24. 76 indexed citations
16.
Qiu, Xiangning, Guiying Zhang, Rong Xiao, et al.. (2012). Acquired hemophilia associated with bullous pemphigoid: a case report.. PubMed. 5(1). 102–4. 8 indexed citations
17.
Qiu, Xiangning, Jeffrey M. Friedman, & Gangning Liang. (2011). Creating a flexible multiple microRNA expression vector by linking precursor microRNAs. Biochemical and Biophysical Research Communications. 411(2). 276–280. 9 indexed citations
18.
Qiu, Xiangning, Christoffer Hother, Ulrik Ralfkiær, et al.. (2010). Equitoxic Doses of 5-Azacytidine and 5-Aza-2′Deoxycytidine Induce Diverse Immediate and Overlapping Heritable Changes in the Transcriptome. PLoS ONE. 5(9). e12994–e12994. 59 indexed citations
19.
Zhou, Ying, Jun Yuan, Yujun Pan, et al.. (2009). T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clinical Immunology. 132(3). 362–370. 79 indexed citations
20.
Hu, Nan, Xiangning Qiu, Yongqi Luo, et al.. (2008). Abnormal histone modification patterns in lupus CD4+ T cells.. PubMed. 35(5). 804–10. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenzo de la Rica Breakdown of academic impact, for papers by Simon Bornschein Breakdown of academic impact, for papers by Xingwen Dong Breakdown of academic impact, for papers by Chiara Angiolilli Breakdown of academic impact, for papers by Annie Yarwood Breakdown of academic impact, for papers by Anke K. Bergmann Breakdown of academic impact, for papers by Ari Itoh‐Nakadai Breakdown of academic impact, for papers by Soumen Chakraborty Breakdown of academic impact, for papers by Yingzhe Yu Breakdown of academic impact, for papers by Laura Bergamaschi
Rankless by CCL
2026